Skip to content

Washington, D.C. – The U.S. Senate is moving the country toward swifter and more comprehensive development of vaccines for and treatments against biological agents that could be used by terrorists, according to U.S. Sen. Mike Enzi, R-Wyo., an original cosponsor of S. 15, the Project Bioshield Act.

"We senators know first-hand the threat of biological agents. Our offices were closed for a time because of their threat," said Enzi. "This bill puts us on the path of preparedness, something we can never have too much of in this post 9/11 world."